J Hirsh. Show Affiliations »
Abstract
Mesh： See more » Administration, OralAdultAgedAngina Pectoris/drug therapyAngina, Unstable/drug therapyAnticoagulants/administration & dosageAnticoagulants/adverse effectsAnticoagulants/therapeutic useAspirin/therapeutic useBlood Coagulation TestsCerebrovascular Disorders/drug therapyClinical Trials as TopicCoronary Disease/drug therapyFemaleHeart Valve Diseases/drug therapyHemorrhage/chemically inducedHeparin/administration & dosageHeparin/adverse effectsHeparin/therapeutic useHumansInjections, SubcutaneousMaleMiddle AgedMyocardial Infarction/drug therapyMyocardial Infarction/mortalityPostoperative Complications/prevention & controlPremedicationRetrospective StudiesThromboembolism/complicationsThrombophlebitis/drug therapyThrombophlebitis/prevention & controlTime Factors
Substances： See more » AnticoagulantsHeparinAspirin
Year: 1986 PMID： 3515557 DOI： 10.1055/s-2007-1003532
Source DB: PubMed Journal: Semin Thromb Hemost ISSN： 0094-6176 Impact factor: 4.180